Previous Article | Next Article 
Journal of Clinical Microbiology, December 1999, p. 4131-4134, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Characteristics of Streptococcus
pyogenes Serotype M1 and M3 Isolates from Patients in Japan from
1981 to 1997
Toshiyuki
Murase,*
Rieko
Suzuki,
Ro
Osawa, and
Shiro
Yamai
Department of Bacteriology and Pathology,
Kanagawa Prefectural Public Health Laboratory, Yokohama 241-0815, Japan
Received 1 March 1999/Returned for modification 26 June
1999/Accepted 21 August 1999
 |
ABSTRACT |
Streptococcus pyogenes isolates obtained in 1981 to
1997 from patients and healthy subjects were characterized by
pulsed-field gel electrophoresis (PFGE) patterns, biotyping, and the
presence of spe genes encoding streptococcal pyrogenic
exotoxins. Changes in the profiles were shown in the serotype M1/T1
isolates from pharyngitis over this period, but not in serotype M3/T3
isolates. The characteristics of isolates from patients with toxic
shock-like syndrome (TSLS) were comparable to those of the other
isolates, including those from healthy subjects. This finding suggests
that further phenotypic and molecular characterization, such as
investigating the genomic difference represented by the pathogenicity
island, of isolates with apparently the same profiles would be
necessary to determine the etiology of diseases caused by S. pyogenes, including TSLS.
 |
TEXT |
Streptococcus pyogenes
(group A Streptococcus) is a major etiological agent causing
a variety of human diseases ranging from pharyngitis to severe invasive
disease, such as toxic shock-like syndrome (TSLS) (13). In
the United States, the predominant serotypes of S. pyogenes
causing TSLS were reported to be M1 and M3 (4, 14, 16).
Molecular profiling of S. pyogenes serotypes M1 and M3 by
pulsed-field gel electrophoresis (PFGE) has demonstrated that the
majority of episodes of invasive disease in the United States have been
caused by clonal spread (3, 7). Identical PFGE patterns had
been observed in isolates from patients with both invasive and
noninvasive diseases in Japan (8). In order to determine the
role of molecular typing in pathogenicity of S. pyogenes,
this report compared strains isolated from patients and healthy
carriers in Kanagawa Prefecture, Japan, during 1981 to 1997.
A total of 73 clinical isolates of S. pyogenes were obtained
from pediatric patients (3 to 9 years old) with pharyngitis living in
Kanagawa Prefecture, Japan, who attended sentinel clinics of the
National Epidemiological Surveillance of Infectious Diseases between
1981 and 1997. A total of 35 S. pyogenes strains were isolated from asymptomatic healthy children (5 to 10 years old) who
were attending 20 different schools in different geographical regions
of Kanagawa Prefecture between 1981 and 1985. The strains were examined
for Lancefield serogroups and T-protein serotypes by using slide
agglutination with commercial rabbit antisera (Denka Seiken Co., Ltd.,
Tokyo, Japan) (5). The strains with serotypes T1 and T3 were
tested for M-protein serotypes by microdiffusion with acid extracts and
rabbit antisera as described elsewhere (12). In addition, a
total of 20 strains derived from TSLS patients (8 to 83 years old)
collected in Japan during 1992 to 1995 had known M and T serotypes
and streptococcal pyrogenic exotoxin A (speA),
speB, and speC genes (5). It was
previously reported (2) that S. pyogenes strains
isolated from patients with pharyngitis or superficial skin infection
showed changes in their restriction profiles between 1988 and 1989. In
this study, we compared S. pyogenes strains obtained
from patients with pharyngitis to those obtained from patients who were
asymptomatic over a 7- to 8-year interval. Strain comparisons were
performed by using PFGE with SmaI-digested (15)
and SfiI-digested (7) chromosomal DNA; PCR-detected speA, speB, or speC genes
(11); and biotyping with a commercial biochemical test kit
(Rapid ID 32 Strep; bioMeriuex, Marcy-l'Etoile, France)
(1). Numerical analysis of SmaI-digested patterns
was performed by identifying the proportion of fragments shared by
pairs of isolates by the method of Nei and Li (9) (also
known as the Dice coefficient of similarity) and calculated as
F = 2nxy/(nx + ny), where nx and
ny are the total numbers of fragments from
isolates x and y, respectively, and
nxy is the number of fragments identical in the
two isolates. An F value for two PFGE patterns of
0.80
represents closely related strains (10).
By following the established criteria for bacterial strain typing by
PFGE methodology (20), S. pyogenes isolates were
classified into types I to III by PFGE analysis with SmaI
(Fig. 1A). PFGE patterns with DNA bands
of 160 and 120 kb and those with DNA bands of 200 and 100 kb were
arbitrarily designated as types I and II, respectively. Those isolates
with four DNA bands (180, 155, 110, and 90 kb) were designated as type
III. Each of the above PFGE patterns was further classified. Subtypes
were determined when the patterns varied by two to four bands compared
with the predominant pattern (i.e., Ia, IIa, and IIIa) of each PFGE
type. The patterns from isolates within type I were distinguished from
a predominant pattern (Ia) by two to four bands and a total of five
patterns (Ia, Ib, Ic, Id, and Ie) were recognized (Fig.
2A). Similarly, four to five PFGE
patterns were observed in isolates within each of the types II and III
(Fig. 2B and C). Since the numbers of differences of bands between the
predominant patterns and the others in each of the types ranged from
two to four, which can be explained by one to two genetic events
(20), the isolates within each PFGE type are considered to
be genetically closely related (F values ranging from 0.80 to 0.91). The PFGE pattern of a serotype M3/T3 isolate was untypeable
(UT) (Table 1 [PFGE data not shown]).
As shown in Fig. 1B, SfiI-digested PFGE patterns were
classified into six types (A through F) in a similar manner. The
patterns of isolates with pattern types A, B, and C were
distinguished by two or three bands from each of the predominant
patterns, named A1, B1, and C1, and a total of five, four, and three
types respectively, were recognized.

View larger version (80K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Representative PFGE patterns of
SmaI-digested chromosomal DNA of S. pyogenes
isolates. Lanes: 1, type Ia; 2, type IIa; 3, type IIIa; M, lambda
ladders. Arrows indicate the fragments which are common within each of
the PFGE types (see text). (B) SfiI-digested patterns of
S. pyogenes isolates. Lanes: 1 and 18, lambda DNA ladder; 2 and 19, Saccharomyces cerevisiae DNA; 3, type A1; 4, type
A2; 5, type A3; 6, type A4; 7, type A5; 8, type B1; 9, type B2; 10, type B3; 11, type B4; 12, type E; 13, type C1; 14, type C2; 15, type
C3; 16, type D; 17, type F. The sizes of the markers (in kilobase
pairs) are indicated to the left of each panel.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Schematic diagram showing the differences between the
PFGE patterns and the predominant patterns in each of the
serotypes types Ia (A), IIa (B), and IIIa (C). Triangles indicate
fragments present in the predominant patterns and missing from those
patterns after a possible genetic event(s); asterisks indicate the
fragment is absent from the predominant patterns, but present in the
patterns after a possible genetic event(s).
|
|
The results of the typing of S. pyogenes isolates in the
present study are summarized in Table 1. Isolates from patients with
pharyngitis in Japan that belonged to serotype M1/T1 showed appreciable
shifts in their phenotypic and genotypic characteristics over the
17-year period between 1981 and 1997. Twenty-four of the 25 serotype
M1/T1 isolates in the first 8-year period (1981 to 1988) were
classified as SmaI-digested PFGE type I and
SfiI-digested type A (SmaI-SfiI:A) and
did not carry the speA gene, although they belonged to
various biotypes. In contrast, 24 of the 26 isolates in the next 9-year
period (1989 to 1997) belonged to PFGE type SmaI:II-SfiI:B and were biotype 1. All of the
type SmaI:II strains except one carried the speA
gene, which seems to have coincided with the first report of the
isolation of the speA-positive strain of serotype M1 in
North Carolina in 1989 (6). A chi-square analysis indicated
that the number of type SmaI:I-SfiI:A isolates significantly decreased (P < 0.001) and the number of
type SmaI:II-SfiI:B isolates increased
(P < 0.001) during this period (1981 to 1997). A
similar shift was observed within S. pyogenes isolates from patients with pharyngitis in a different part of Japan (Toyama Prefecture) in which SmaI-digested PFGE patterns and
biotypes of isolates obtained in 1987 to 1988 were different from those in 1991 to 1993 (19). These data imply that the type
SmaI:II-SfiI:B strains in this study may have an
etiological advantage, because of either ineffectiveness of previous
acquired immunity or inadequate immunity against these strains in the
overall population. The PFGE patterns observed in 19 of the 26 M1/T1
serotype isolates from patients with pharyngitis in 1989 to 1997 were
identical to those of TSLS-associated isolates. As for serotype M3/T3,
all isolates from both patients and healthy subjects except one were classified as PFGE type SmaI:III-SfiI:C or
SmaI:III-SfiI:D and carried both speA
and speB genes.
Musser et al. (7) analyzed strains expressing M1 protein
from 13 countries on five continents (Japan not included) by
comparing PFGE patterns of SfiI-digested
chromosomal DNA. They concluded that most invasive disease
episodes were caused by a distinct subclone that spread among the
countries. The results of the present study confirm their findings.
Although we have not examined isolates from their study, the pattern B1
that was shown in SfiI-digested chromosomal DNA of M1/T1
serotype strains obtained from patients with TSLS in this study
appeared to be identical to the published PFGE pattern of the subclone
revealed by Musser et al. (7). However, the patterns
observed in serotype M1/T1 isolates from patients with pharyngitis in
1989 to 1997 were identical to those of TSLS-associated isolates.
Interestingly, the SmaI-digested pattern (IIa) was
comparable to the published PFGE patterns of the isolates from patients
with pharyngotonsillitis and TSLS in Europe and the United States
(3, 6, 10, 15). In the present study, the association of
both genotypic and phenotypic characteristics of the M3 isolates with
their pathogenicities seems to be obscure, since the profiles observed
in healthy subjects were identical to those of the TSLS-associated
isolates. Two possibilities can be raised in this context. One
possibility is that the occurrence of TSLS is related to the
susceptibility of individuals to a particular strain. Stevens
(17) considered that the preexisting immunity against
virulence factors of S. pyogenes, such as M proteins and streptococcal pyrogenic exotoxins, participates in the clinical syndrome and outcome of infection. Kiska et al. (6)
suggested that cases of pharyngeal infections might have served as a
reservoir for virulent strains in persons susceptible to invasive
infection. Alternatively, novel virulence factors not found in the
strains from the healthy subjects could be possessed by those
TSLS-associated strains. Recently, Stockbauer et al. (18)
revealed that considerable variations in a particular gene encoding a
streptococcal inhibitor of complement, which would aid the bacterium to
avoid the host's immune response in infection, existed among serotype
M1 isolates that apparently belonged to the same clone. Further
phenotypic and molecular characterization of isolates with apparently
the "same" genotypic and phenotypic profiles would be necessary in order to elucidate the etiology of TSLS.
 |
ACKNOWLEDGMENTS |
We are grateful to R. A. Whiley of the Department of Oral
Microbiology, St. Bartholomew's and Royal London School of Medicine and Dentistry.
This work was carried out under the Research on Emerging and Reemerging
Infectious Diseases, Health Sciences Research Grants, provided by the
Ministry of Health and Welfare (Japan).
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Veterinary Microbiology, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan. Phone: 81-857-31-5430. Fax:
81-857-31-5430. E-mail: molamolatm{at}aol.com.
 |
REFERENCES |
| 1.
|
Bouvet, A.,
P. Geslin,
P. Kriz-Kuzemenska,
V. Blanc,
C. Devine, and F. Grimont.
1994.
Restricted association between biotypes and serotypes within group A streptococci.
J. Clin. Microbiol.
32:1312-1317[Abstract/Free Full Text].
|
| 2.
|
Cleary, P. P.,
E. L. Kaplan,
J. P. Handley,
A. Wlazlo,
M. H. Kim,
A. R. Hauser, and P. M. Schlievert.
1992.
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s.
Lancet
339:518-521[Medline].
|
| 3.
|
Cockerill, F. R., III,
R. L. Thomson,
J. M. Musser,
P. M. Schlievert,
J. Talbot,
K. E. Holley,
W. S. Harmsen,
D. M. Ilstrup,
P. C. Kohner,
M. H. Kim,
B. Frankfort,
J. M. Manahan,
J. M. Steckelberg,
F. Roberson,
W. R. Wilson, and the Southeastern Minnesota Streptococcal Working Group.
1998.
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease.
Clin. Infect. Dis.
26:1448-1458[Medline].
|
| 4.
|
Hauser, A. R.,
D. L. Stevens,
E. L. Kaplan, and P. M. Schlievert.
1991.
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome.
J. Clin. Microbiol.
29:1562-1567[Abstract/Free Full Text].
|
| 5.
|
Inagaki, Y.,
T. Konda,
S. Murayama,
S. Yamai,
A. Matsushima,
Y. Gyobu,
D. Tanaka,
A. Tamaru,
C. Katsukawa,
A. Katayama,
M. Tomita,
Y. Fuchi,
K. Hoashi,
H. Watanabe, and the Working Group for Group A Streptococci in Japan.
1997.
Serotyping of Streptococcus pyogenes isolated from common and severe invasive infections in Japan, 1990-5: implication of the T3 serotype strain-expansion in TSLS.
Epidemiol. Infect.
119:41-48[Medline].
|
| 6.
|
Kiska, D. L.,
B. Thiede,
J. Caracciolo,
M. Jordan,
D. Johnson,
E. L. Kaplan,
R. P. Gruninger,
J. A. Lohr,
P. H. Gilligan, and F. W. Denny, Jr.
1997.
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms.
J. Infect. Dis.
176:992-1000[Medline].
|
| 7.
|
Musser, J. M.,
V. Kapur,
J. Szeto,
X. Pan,
D. S. Swanson, and D. R. Martin.
1995.
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.
Infect. Immun.
63:994-1003[Abstract].
|
| 8.
|
Nakashima, K.,
S. Ichiyama,
Y. Iimura,
Y. Hasegawa,
M. Ohta,
K. Ooe,
Y. Shimizu,
H. Igarashi,
T. Murai, and K. Shimokata.
1997.
A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints.
Clin. Infect. Dis.
25:260-266[Medline].
|
| 9.
|
Nei, M., and W. H. Li.
1979.
Mathematical model for studying genetic variation in terms of restriction endonucleases.
Proc. Natl. Acad. Sci. USA
76:5269-5273[Abstract/Free Full Text].
|
| 10.
|
Nguyen, L.,
D. Levy,
A. Ferroni,
P. Gehanno, and P. Berche.
1997.
Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic.
J. Clin. Microbiol.
35:2111-2114[Abstract].
|
| 11.
|
Norgren, M.,
A. Norrby, and S. E. Holm.
1992.
Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection.
J. Infect. Dis.
166:1014-1020[Medline].
|
| 12.
|
Rotta, J., and R. R. Facklam.
1980.
Manual of microbiological diagnostic methods for streptococcal infections and their sequelae.
Bull. W. H. O.
1:1-50.
|
| 13.
|
Ruoff
1998.
Streptococcal diseases, p. 257-275.
In
L. Collier, A. Balows, and M. Sussman (ed.), Topley and Wilson's microbiology and microbial infections, 9th ed., vol. 3. Arnold, London, United Kingdom.
|
| 14.
|
Schwartz, B.,
R. R. Facklam, and R. F. Breiman.
1990.
Changing epidemiology of group A streptococcal infection in the USA.
Lancet
336:1167-1171[Medline].
|
| 15.
|
Stanley, J.,
D. Linton,
M. Desai,
A. Efstratiou, and R. George.
1995.
Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease.
J. Clin. Microbiol.
33:2850-2855[Abstract].
|
| 16.
|
Stevens, D. L.
1995.
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
Emerg. Infect. Dis.
1:69-78[Medline].
|
| 17.
|
Stevens, D. L.
1992.
Invasive group streptococcus infections.
Clin. Infect. Dis.
14:2-13[Medline].
|
| 18.
|
Stockbauer, K. E.,
D. Grigsby,
X. Pan,
Y.-X. Fu,
L. M. Perea Mejia,
A. Cravioto, and J. M. Musser.
1998.
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus.
Proc. Natl. Acad. Sci. USA
95:3128-3133[Abstract/Free Full Text].
|
| 19.
|
Tanaka, D.,
Y. Gyobu, and H. Kodama.
1996.
Typing of group A streptococci by pulsed field gel electrophoresis.
Kansenshogaku Zasshi
70:283-286[Medline].
|
| 20.
|
Tenover, F. C.,
R. D. Arbeit,
R. V. Goering,
P. A. Mickelsen,
B. E. Murray,
D. H. Persing, and B. Swaminathan.
1995.
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
J. Clin. Microbiol.
33:2233-2239[Medline].
|
Journal of Clinical Microbiology, December 1999, p. 4131-4134, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nakagawa, I., Kurokawa, K., Yamashita, A., Nakata, M., Tomiyasu, Y., Okahashi, N., Kawabata, S., Yamazaki, K., Shiba, T., Yasunaga, T., Hayashi, H., Hattori, M., Hamada, S.
(2003). Genome Sequence of an M3 Strain of Streptococcus pyogenes Reveals a Large-Scale Genomic Rearrangement in Invasive Strains and New Insights into Phage Evolution. Genome Res
13: 1042-1055
[Abstract]
[Full Text]
-
Nunes De Melo, M. C., Figueiredo, A. M. S., Ferreira-Carvalho, B. T.
(2003). Antimicrobial susceptibility patterns and genomic diversity in strains of Streptococcus pyogenes isolated in 1978-1997 in different Brazilian cities. J Med Microbiol
52: 251-258
[Abstract]
[Full Text]
-
Ikebe, T., Wada, A., Inagaki, Y., Sugama, K., Suzuki, R., Tanaka, D., Tamaru, A., Fujinaga, Y., Abe, Y., Shimizu, Y., Watanabe, H., the Working Group for Group A Streptococci in Japa,
(2002). Dissemination of the Phage-Associated Novel Superantigen Gene speL in Recent Invasive and Noninvasive Streptococcus pyogenes M3/T3 Isolates in Japan. Infect. Immun.
70: 3227-3233
[Abstract]
[Full Text]